Average Co-Inventor Count = 12.95
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Corporation (13 from 1,829 patents)
2. Pharmacopeia Drug Discovery, Inc. (6 from 52 patents)
3. Pharmacopeia Inc. (5 from 101 patents)
4. Merck Sharp + Dohme Corp. (1 from 2,405 patents)
15 patents:
1. 8673924 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
2. 8288371 - Ortho pyrrolidine, benzyl-substituted heterocycle CCR1 antagonists for autoimmune diseases and inflammation
3. 7807683 - N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
4. 7514442 - Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors
5. 7511049 - Pyrazolopyrimidines as cyclin dependent kinase inhibitors
6. 7470695 - N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
7. 7468372 - Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors
8. 7342016 - Farnesyl protein transferase inhibitors as antitumor agents
9. 7309705 - Pyrazolopyrimidines as cyclin dependent kinase inhibitors
10. 7161003 - Pyrazolopyrimidines as cyclin dependent kinase inhibitors
11. 7119200 - Pyrazolopyrimidines as cyclin dependent kinase inhibitors
12. 7084271 - Pyrazolopyrimidines as cyclin dependent kinase inhibitors
13. 7078525 - Pyrazolopyrimidines as cyclin dependent kinase inhibitors
14. 7074924 - Pyrazolopyrimidines as cyclin dependent kinase inhibitors
15. 7067661 - Pyrazolopyrimidines as cyclin dependent kinase inhibitors